Pain and bleeding pattern related to levonorgestrel intrauterine system (LNG-IUS) insertion. 2013

Dominique Van Schoubroeck, and Thierry Van den Bosch, and Lieveke Ameye, and Joan Veldman, and An Hindryckx, and Erika Werbrouck, and Dirk Timmerman
KU Leuven Department of Development and Regeneration, Leuven, Belgium. Electronic address: Dominique.vanschoubroeck@uzleuven.be.

OBJECTIVE To investigate whether the pattern or pain or bleeding during levonorgestrel intrauterine system (LNG-IUS) insertion and in the first 6 weeks thereafter is altered by LNG-IUS malposition. METHODS Prospective cohort of 413 women undergoing LNG-IUS insertion or replacement. A first questionnaire on pain perception was completed by the women immediately after insertion. In a second questionnaire the women were asked to record pain in the 3 days following insertion and both pain and bleeding from 4 to 6 weeks after insertion. Six weeks after insertion a 2D- and 3D-ultrasound examination was performed to evaluate the position of the LNG-IUS and of the uterus. RESULTS Parity was inversely related to pain at insertion, in the first 3 days and at 4-6 weeks. LNG-IUS insertion was less painful in the postpartum period. Women who had had a LNG-IUS as prior contraceptive method reported a higher percentage of amenorrhea at 4-6 weeks. The position of the LNG-IUS or of the uterus did not influence the pain scores or the bleeding pattern. The fact that the LNG-IUS arms appeared embedded in the uterine wall on coronal 3D-volume reconstruction did not influence pain or the bleeding pattern. CONCLUSIONS Because neither pain nor bleeding is a reliable predictor of LNG-IUS position, we suggest an ultrasound examination to confirm correct LNG-IUS placement in all patients at about 6 weeks after insertion.

UI MeSH Term Description Entries
D007436 Intrauterine Devices, Medicated Intrauterine devices that release contraceptive agents. Hormone-Releasing IUDs,IUD, Hormone Releasing,Intrauterine Devices, Hormone-Releasing,Intrauterine Devices, Progesterone-Releasing,Medicated Intrauterine Devices,Device, Hormone-Releasing Intrauterine,Device, Medicated Intrauterine,Device, Progesterone-Releasing Intrauterine,Devices, Hormone-Releasing Intrauterine,Devices, Medicated Intrauterine,Devices, Progesterone-Releasing Intrauterine,Hormone Releasing IUD,Hormone-Releasing IUD,Hormone-Releasing Intrauterine Device,Hormone-Releasing Intrauterine Devices,IUD, Hormone-Releasing,IUDs, Hormone-Releasing,Intrauterine Device, Hormone-Releasing,Intrauterine Device, Medicated,Intrauterine Device, Progesterone-Releasing,Intrauterine Devices, Hormone Releasing,Intrauterine Devices, Progesterone Releasing,Medicated Intrauterine Device,Progesterone-Releasing Intrauterine Device,Progesterone-Releasing Intrauterine Devices
D010146 Pain An unpleasant sensation induced by noxious stimuli which are detected by NERVE ENDINGS of NOCICEPTIVE NEURONS. Suffering, Physical,Ache,Pain, Burning,Pain, Crushing,Pain, Migratory,Pain, Radiating,Pain, Splitting,Aches,Burning Pain,Burning Pains,Crushing Pain,Crushing Pains,Migratory Pain,Migratory Pains,Pains, Burning,Pains, Crushing,Pains, Migratory,Pains, Radiating,Pains, Splitting,Physical Suffering,Physical Sufferings,Radiating Pain,Radiating Pains,Splitting Pain,Splitting Pains,Sufferings, Physical
D010298 Parity The number of offspring a female has borne. It is contrasted with GRAVIDITY, which refers to the number of pregnancies, regardless of outcome. Multiparity,Nulliparity,Primiparity,Parity Progression Ratio,Parity Progression Ratios,Ratio, Parity Progression,Ratios, Parity Progression
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D003271 Contraceptive Agents, Female Chemical substances or agents with contraceptive activity in females. Use for female contraceptive agents in general or for which there is no specific heading. Contraceptives, Female,Agents, Female Contraceptive,Female Contraceptive Agents,Female Contraceptives
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000568 Amenorrhea Absence of menstruation. Postpartum Amenorrhea,Amenorrhea, Postpartum,Postpartum Amenorrheas
D014463 Ultrasonography The visualization of deep structures of the body by recording the reflections or echoes of ultrasonic pulses directed into the tissues. Use of ultrasound for imaging or diagnostic purposes employs frequencies ranging from 1.6 to 10 megahertz. Echography,Echotomography,Echotomography, Computer,Sonography, Medical,Tomography, Ultrasonic,Ultrasonic Diagnosis,Ultrasonic Imaging,Ultrasonographic Imaging,Computer Echotomography,Diagnosis, Ultrasonic,Diagnostic Ultrasound,Ultrasonic Tomography,Ultrasound Imaging,Diagnoses, Ultrasonic,Diagnostic Ultrasounds,Imaging, Ultrasonic,Imaging, Ultrasonographic,Imaging, Ultrasound,Imagings, Ultrasonographic,Imagings, Ultrasound,Medical Sonography,Ultrasonic Diagnoses,Ultrasonographic Imagings,Ultrasound, Diagnostic,Ultrasounds, Diagnostic

Related Publications

Dominique Van Schoubroeck, and Thierry Van den Bosch, and Lieveke Ameye, and Joan Veldman, and An Hindryckx, and Erika Werbrouck, and Dirk Timmerman
April 2011, Journal of the College of Physicians and Surgeons--Pakistan : JCPSP,
Dominique Van Schoubroeck, and Thierry Van den Bosch, and Lieveke Ameye, and Joan Veldman, and An Hindryckx, and Erika Werbrouck, and Dirk Timmerman
April 2007, Ceska gynekologie,
Dominique Van Schoubroeck, and Thierry Van den Bosch, and Lieveke Ameye, and Joan Veldman, and An Hindryckx, and Erika Werbrouck, and Dirk Timmerman
January 2012, Acta obstetricia et gynecologica Scandinavica,
Dominique Van Schoubroeck, and Thierry Van den Bosch, and Lieveke Ameye, and Joan Veldman, and An Hindryckx, and Erika Werbrouck, and Dirk Timmerman
August 2004, Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology,
Dominique Van Schoubroeck, and Thierry Van den Bosch, and Lieveke Ameye, and Joan Veldman, and An Hindryckx, and Erika Werbrouck, and Dirk Timmerman
February 2010, Human reproduction (Oxford, England),
Dominique Van Schoubroeck, and Thierry Van den Bosch, and Lieveke Ameye, and Joan Veldman, and An Hindryckx, and Erika Werbrouck, and Dirk Timmerman
April 2013, Contraception,
Dominique Van Schoubroeck, and Thierry Van den Bosch, and Lieveke Ameye, and Joan Veldman, and An Hindryckx, and Erika Werbrouck, and Dirk Timmerman
November 2002, Journal of anatomy,
Dominique Van Schoubroeck, and Thierry Van den Bosch, and Lieveke Ameye, and Joan Veldman, and An Hindryckx, and Erika Werbrouck, and Dirk Timmerman
July 2019, Revista da Associacao Medica Brasileira (1992),
Dominique Van Schoubroeck, and Thierry Van den Bosch, and Lieveke Ameye, and Joan Veldman, and An Hindryckx, and Erika Werbrouck, and Dirk Timmerman
December 2004, Gynecologic oncology,
Dominique Van Schoubroeck, and Thierry Van den Bosch, and Lieveke Ameye, and Joan Veldman, and An Hindryckx, and Erika Werbrouck, and Dirk Timmerman
September 2006, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception,
Copied contents to your clipboard!